PubRank
Search
About
Kay Savage
Author PubWeight™ 44.13
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Oncogenic Braf induces melanocyte senescence and melanoma in mice.
Cancer Cell
2009
4.76
2
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.
Clin Cancer Res
2006
2.15
3
A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer.
Clin Cancer Res
2010
1.96
4
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.
Breast Cancer Res Treat
2007
1.84
5
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.
Mod Pathol
2010
1.79
6
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas.
J Pathol
2010
1.79
7
Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue.
BMC Cell Biol
2008
1.75
8
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors.
Sci Transl Med
2010
1.64
9
Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.
Mod Pathol
2006
1.62
10
Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization.
Lab Invest
2006
1.59
11
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.
Breast Cancer Res
2005
1.59
12
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.
Clin Cancer Res
2009
1.49
13
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.
Eur J Cancer
2010
1.40
14
Integrated functional, gene expression and genomic analysis for the identification of cancer targets.
PLoS One
2009
1.33
15
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.
Mod Pathol
2006
1.28
16
Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas.
Clin Cancer Res
2011
1.27
17
Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
J Pathol
2010
1.25
18
The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.
J Pathol
2010
1.23
19
Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development.
Gene Expr Patterns
2006
1.21
20
MYC amplification in breast cancer: a chromogenic in situ hybridisation study.
J Clin Pathol
2006
1.14
21
Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha.
Cancer Res
2007
1.11
22
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.
J Pathol
2009
1.08
23
The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo.
Cancer Res
2007
1.07
24
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer.
Breast Cancer Res Treat
2007
1.05
25
Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation.
J Pathol
2009
0.95
26
Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.
Mod Pathol
2010
0.93
27
Oncocytic change in pleomorphic adenoma: molecular evidence in support of an origin in neoplastic cells.
J Clin Pathol
2006
0.93
28
Effect of vein graft harvesting on endothelial nitric oxide synthase and nitric oxide production.
Ann Thorac Surg
2005
0.93
29
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study.
Mod Pathol
2010
0.92
30
β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
Mod Pathol
2010
0.89
31
Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity.
J Thorac Cardiovasc Surg
2009
0.81
32
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
Breast Cancer Res Treat
2010
0.81
33
Endocytosis of anti-CCK-B/gastrin receptor antibody and effect on hepatoma cell lines.
J Histochem Cytochem
2002
0.75
34
Expression of c-kit (CD117) in neuroendocrine tumours--a target for therapy?
Oncol Rep
2005
0.75